018396309
EPYMOND
February 10, 2021
Trademark Summary
The trademark EPYMOND was filed by Bayer Aktiengesellschaft, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 1, 2021, and received one opposition filed on May 30, 2021 by CSL Behring L.L.C. on Likelihood of confusion. the opponent was represented by Schöne de la Nuez, Frank and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 30, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 11, 2022.
Goods And Services
- The mark was filed in class 5 with following description of goods:
- Pharmaceutical products for the treatment of cardiovascular diseases
- Pharmaceutical products for the treatment of cancer
- Pharmaceutical products for the treatment of diabetes
- Anti-infectives
- Pharmaceutical products for use in cell and gene therapy.
